Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'LIPODYSTROPHY' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 330 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. David, MH; Hornung, R; Fichtenbaum, CJ
      Ischemic cardiovascular disease in persons with human immunodeficiency virus infection

      CLINICAL INFECTIOUS DISEASES
    2. Raulin, J
      Human immunodeficiency virus and host cell lipids. Interesting pathways inresearch for a new HIV therapy

      PROGRESS IN LIPID RESEARCH
    3. Mahajan, AP; Tashima, KT; Bausserman, LL; Flynn, MM; Carpenter, CCJ
      Plateau in body habitus changes and serum lipid abnormalities in HIV-positive women on highly active antiretroviral therapy: A 3.5-year study

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    4. Moyle, G; Baldwin, C; Mandalia, S; Comitis, S; Burn, P; Gazzard, B
      Changes in metabolic parameters and body shape after replacement of protease inhibitor with efavirenz in virologically controlled HIV-1-positive persons: Single-arm observational cohort

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    5. Monforte, AD; Bugarini, R; Pezzotti, P; De Luca, A; Antinori, A; Mussini, C; Vigevani, GM; Tirelli, U; Bruno, R; Gritti, F; Piazza, M; Chigiotti, S; Chirianni, A; De Stefano, C; Pizzigallo, E; Perrella, O; Moroni, M
      Low frequency of severe hepatotoxicity and association with HCV coinfection in HIV-positive patients treated with HAART

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    6. Rakotoambinina, B; Medioni, J; Rabian, C; Jubault, V; Jais, JP; Viard, JP
      Lipodystrophic syndromes and hyperlipidemia in a cohort of HIV-1-infected patients receiving triple combination antiretroviral therapy with a protease inhibitor

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    7. Ruiz, L; Negredo, E; Domingo, P; Paredes, R; Francia, E; Balague, M; Gel, S; Bonjoch, A; Fumaz, CR; Johnston, S; Romeu, J; Lange, J; Clotet, B
      Antiretroviral treatment simplification with nevirapine in protease inhibitor-experienced patients with HIV-associated lipodystrophy

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    8. Bogner, JR; Vielhauer, V; Beckmann, RA; Michl, G; Wille, L; Salzberger, B; Goebel, FD
      Stavudine versus zidovudine and the development of lipodystrophy

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    9. Duong, M; Petit, JM; Piroth, L; Grappin, M; Buisson, M; Chavanet, P; Hillon, S; Portier, H
      Association between insulin resistance and hepatitis C virus chronic infection in HIV-hepatitis C virus-coinfected patients undergoing antiretroviraltherapy

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    10. Arpadi, SM; Cuff, PA; Horlick, M; Wang, J; Kotler, DP
      Lipodystrophy in HIV-infected children is associated with high viral load and low CD4(+)-lymphocyte count and CD4(+)-lymphocyte percentage at baseline and use of protease inhibitors and stavudine

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    11. Mulligan, K; Tai, VW; Algren, H; Abrams, DI; Leiser, RJ; Lo, JC; Schambelan, M
      Altered fat distribution in HIV-positive men on nucleoside analog reverse transcriptase inhibitor therapy

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    12. Schmitz, M; Michl, GM; Walli, R; Bogner, J; Bedynek, A; Seidel, D; Goebel, FD; Demant, T
      Alterations of apolipoprotein B metabolism in HIV-infected patients with antiretroviral combination therapy

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    13. Maijgren-Steffensson, C; Sonnerborg, A; Vahlne, A; Britton, S; Larsson, S; Ahrlund-Richter, L
      Smaller amounts of antiretroviral drugs are needed when combined with an active ribozyme against HIV-1

      MOLECULAR THERAPY
    14. Hegele, RA
      Molecular basis of partial lipodystrophy and prospects for therapy

      TRENDS IN MOLECULAR MEDICINE
    15. Cao, H; Yuen, J; Hegele, RA
      Single nucleotide polymorphisms of the fukutin gene

      JOURNAL OF HUMAN GENETICS
    16. Hegele, RA; Cao, HN
      Single nucleotide polymorphisms of RXRA encoding retinoid X receptor alpha

      JOURNAL OF HUMAN GENETICS
    17. Burke, B; Mounkes, LC; Stewart, C
      The nuclear envelope in muscular dystrophy and cardiovascular diseases

      TRAFFIC
    18. Shahmanesh, M; Jaleel, H; DeSilva, Y; Ross, JDC; Caslake, M; Cramb, R
      Protease inhibitor related type III hyperlipoproteinaemia is common and not associated with apolipoprotein-E E2/E2 phenotype

      SEXUALLY TRANSMITTED INFECTIONS
    19. Garcia-Viejo, MA; Ruiz, M; Martinez, E
      Strategies for treating HIV-related lipodystrophy

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    20. Borderi, M; Verucchi, G; Tadolini, M; Spinosa, S; Fortunato, L; Talo, S; Chiodo, F
      Metabolic complications of HIV-1 antiretroviral therapy: The lipodystrophysyndrome

      MICROBIOLOGICA
    21. Weyer, C; Wolford, JK; Hanson, RL; Foley, JE; Tataranni, PA; Bogardus, C; Pratley, RE
      Subcutaneous abdominal adipocyte size, a predictor of type 2 diabetes, is linked to chromosome 1q21-q23 and is associated with a common polymorphism in LMNA in Pima Indians

      MOLECULAR GENETICS AND METABOLISM
    22. Berg, AH; Combs, TP; Du, XL; Brownlee, M; Scherer, P
      The adipocyte-secreted protein Acrp30 enhances hepatic insulin action

      NATURE MEDICINE
    23. Liang, JS; Distler, O; Cooper, DA; Jamil, H; Deckelbaum, RJ; Ginsberg, HN; Sturley, SL
      HIV protease inhibitors protect apolipoprotein B from degradation by the proteasome: A potential mechanism for protease inhibitor-induced hyperlipidemia

      NATURE MEDICINE
    24. Chastain, MA; Chastain, JB; Coleman, WP
      HIV lipodystrophy: Review of the syndrome and report of a case treated with liposuction

      DERMATOLOGIC SURGERY
    25. Jakobs, PM; Hanson, EL; Crispell, KA; Toy, W; Keegan, H; Schilling, K; Icenogle, TB; Litt, M; Hershberger, RE
      Novel lamin A/C mutations in two families with dilated cardiomyopathy and conduction system disease

      JOURNAL OF CARDIAC FAILURE
    26. Magre, J; Delepine, M; Khallouf, E; Gedde-Dahl, T; Van Maldergem, L; Sobel, E; Papp, J; Meier, M; Megarbane, A; Lathrop, M; Capeau, J
      Identification of the gene altered in Berardinelli-Seip congenital lipodystrophy on chromosome 11q13

      NATURE GENETICS
    27. Hughes, CA; Taylor, GD
      Metformin in an HIV-infected patient with protease inhibitor-induced diabetic ketoacidosis

      ANNALS OF PHARMACOTHERAPY
    28. Hadigan, C; Jeste, S; Anderson, EJ; Tsay, R; Cyr, H; Grinspoon, S
      Modifiable dietary habits and their relation to metabolic abnormalities inmen and women with human immunodeficiency virus infection and fat redistribution

      CLINICAL INFECTIOUS DISEASES
    29. Mounkes, LC; Burke, B; Stewart, CL
      The A-type lamins - Nuclear structural proteins as a focus for muscular dystrophy and cardiovascular diseases

      TRENDS IN CARDIOVASCULAR MEDICINE
    30. Grinspoon, S
      Insulin resistance in the HIV-lipodystrophy syndrome

      TRENDS IN ENDOCRINOLOGY AND METABOLISM
    31. Holt, I; Clements, L; Manilal, S; Brown, SC; Morris, GE
      The R482Q lamin A/C mutation that causes lipodystrophy does not prevent nuclear targeting of lamin A in adipocytes or its interaction with emerin

      EUROPEAN JOURNAL OF HUMAN GENETICS
    32. Kitaguchi, T; Matsubara, S; Sato, M; Miyamoto, K; Hirai, S; Schwartz, K; Bonne, G
      A missense mutation in the exon 8 of lamin A/C gene in a Japanese case of autosomal dominant limb-girdle muscular dystrophy and cardiac conduction block

      NEUROMUSCULAR DISORDERS
    33. Mooser, V; Carr, A
      Antiretroviral therapy-associated hyperlipidaemia in HIV disease

      CURRENT OPINION IN LIPIDOLOGY
    34. Herman, JS; Easterbrook, PJ
      The metabolic toxicities of antiretroviral therapy

      INTERNATIONAL JOURNAL OF STD & AIDS
    35. Allan, DA; Behrman, AJ
      Lipid abnormalities in a healthcare worker receiving HIV prophylaxis

      INTERNATIONAL JOURNAL OF STD & AIDS
    36. Vergis, EN; Paterson, DL; Wagener, MM; Swindells, S; Singh, N
      Dyslipidaemia in HIV-infected patients: association with adherence to potent antiretroviral therapy

      INTERNATIONAL JOURNAL OF STD & AIDS
    37. Walli, R; Michl, GM; Bogner, JR; Goebel, FD
      Improvement of HAART-associated insulin resistance and dyslipidemia after replacement of protease inhibitors with abacavir

      EUROPEAN JOURNAL OF MEDICAL RESEARCH
    38. Zietz, B; Barth, N; Scholmerich, J; Schmitz, G; Schaffler, A
      Gly15Gly polymorphism within the human adipocyte-specific apM-1gene but not Tyr111His polymorphism is associated with higher levels of cholesterol and LDL-cholesterol in caucasian patients with type 2 diabetes

      EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
    39. Bulbul, M; Erdogan, O; Demircin, G; Altuntas, B; Memis, L; Oner, AE
      Acute pancreatitis in a patient with partial lipodystrophy and membranoproliferative glomerulonephritis

      NEPHROLOGY DIALYSIS TRANSPLANTATION
    40. Melvin, AJ; Lennon, S; Mohan, KM; Purnell, JQ
      Metabolic abnormalities in HIV type 1-infected children treated and not treated with protease inhibitors

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    41. Salina, D; Bodoor, K; Enarson, P; Raharjo, WH; Burke, B
      Nuclear envelope dynamics

      BIOCHEMISTRY AND CELL BIOLOGY-BIOCHIMIE ET BIOLOGIE CELLULAIRE
    42. Kostalova, L; Leskova, F; Kapellerova, A; Strbak, V
      Body mass, plasma leptin, glucose, insulin and C-peptide in offspring of diabetic and non-diabetic mothers

      EUROPEAN JOURNAL OF ENDOCRINOLOGY
    43. Saves, M; Mercie, P; Chene, G
      Lipodystrophic syndrome and antiretroviral treatments in HIV-infected patients

      M S-MEDECINE SCIENCES
    44. Verges, B; Petit, JM
      Lipid anomalies in patients treated with HIV-1 protease inhibitors

      PRESSE MEDICALE
    45. Mauss, S; Schmutz, G
      The HIV-associated lipodystrophy syndrome

      MEDIZINISCHE KLINIK
    46. Huemer, C; Kitson, H; Malleson, PN; Sanderson, S; Huemer, M; Cabral, DA; Chanoine, JP; Petty, RE
      Lipodystrophy in patients with juvenile dermatomyositis - Evaluation of clinical and metabolic abnormalities

      JOURNAL OF RHEUMATOLOGY
    47. Nistal, M; Gonzalez-Peramato, P; Paniagua, R
      Lipomembranous fat necrosis in three cases of testicular torsion

      HISTOPATHOLOGY
    48. Muller-Wieland, D; Knebel, B; Avci, H; Lehr, S; Laudes, M; Ristow, M; Krone, W; Kotzka, J
      Insulin-regulated transcription factors: molecular link between insulin resistance and cardiovascular risk factors

      INTERNATIONAL JOURNAL OF OBESITY
    49. Sewry, CA; Brown, SC; Mercuri, E; Bonne, G; Feng, L; Camici, G; Morris, GE; Muntoni, F
      Skeletal muscle pathology in autosomal dominant Emery-Dreifuss muscular dystrophy with lamin A/C mutations

      NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
    50. Macallan, DC
      Metabolic syndromes in human immunodeficiency virus infection

      HORMONE RESEARCH
    51. Kazlauskaite, R; Santomauro, AT; Goldman, J; Silver, K; Snitker, S; Beamer, BA; Yen, CJ; Shuldiner, AR; Wajchenberg, BL
      A case of congenital generalized lipodystrophy: metabolic effects of four dietary regimens. Lack of association of CGL with polymorphism in the laminA/C Gene

      CLINICAL ENDOCRINOLOGY
    52. Collins, RL; Kanouse, DE; Gifford, AL; Senterfitt, JW; Schuster, MA; McCaffrey, DF; Shapiro, MF; Wenger, NS
      Changes in health-promoting behavior following diagnosis with HIV: Prevalence and correlates in a national probability sample

      HEALTH PSYCHOLOGY
    53. Huang, JS; Rietschel, P; Hadigan, CM; Rosenthal, DI; Grinspoon, S
      Increased abdominal visceral fat is associated with reduced bone density in HIV-infected men with lipodystrophy

      AIDS
    54. White, DJ; Mital, D; Taylor, S; St John, JC
      Sperm mitochondrial DNA deletions as a consequence of long term highly active antiretroviral therapy

      AIDS
    55. van der Valk, M; Gisolf, EH; Reiss, P; Wit, FWNM; Japour, A; Weverling, GJ; Danner, SA
      Increased risk of lipodystrophy when nucleoside analogue reverse transcriptase inhibitors are included with protease inhibitors in the treatment of HIV-1 infection

      AIDS
    56. Castetbon, K; Anglaret, X; Attia, A; Toure, S; Dakoury-Dogbo, N; Messou, E; N'Dri-Yoman, T; Dabis, F; Salamon, R
      Effect of early chemoprophylaxis with co-trimoxazole on nutritional statusevolution in HIV-1-infected adults in Abidjan, Cote d'Ivoire

      AIDS
    57. Noor, MA; Lo, JC; Mulligan, K; Schwarz, JM; Halvorsen, RA; Schambelan, M; Grunfeld, C
      Metabolic effects of indinavir in healthy HIV-seronegative men

      AIDS
    58. John, M; Moore, CB; James, IR; Nolan, D; Upton, RP; McKinnon, EJ; Mallal, SA
      Chronic hyperlactatemia in HIV-infected patients taking antiretroviral therapy

      AIDS
    59. Pernerstorfer-Schoen, H; Jilma, B; Perschler, A; Wichlas, S; Schindler, K; Schindl, A; Rieger, A; Wagner, OF; Quehenberger, P
      Sex differences in HAART-associated dyslipidaemia

      AIDS
    60. Moyle, G
      Mitochondrial toxicity hypothesis for lipoatrophy: a refutation

      AIDS
    61. Heath, KV; Hogg, RS; Chan, KJ; Harris, M; Montessori, V; O'Shaughnessy, MV; Montaner, JSG
      Lipodystrophy-associated morphological, cholesterol and triglyceride abnormalities in a population-based HIV/AIDS treatment database

      AIDS
    62. Gharakhanian, S
      The HIV-associated lipodystrophy syndrome: Research, results, yet more questions

      AIDS
    63. Urso, R; Gentile, M
      Are 'buffalo hump' syndrome, Madelung's disease and multiple symmetrical lipomatosis variants of the same dysmetabolism?

      AIDS
    64. van der Valk, M; Bisschop, PH; Romijn, JA; Ackermans, MT; Lange, JMA; Endert, E; Reiss, P; Sauerwein, HP
      Lipodystrophy in HIV-1-positive patients is associated with insulin resistance in multiple metabolic pathways

      AIDS
    65. Schmidt, HHJ
      Where does insulin resistance in lipodystrophic HIV-1-positive subjects come from?

      AIDS
    66. Shevitz, A; Wanke, CA; Falutz, J; Kotler, DP
      Clinical perspectives on HIV-associated lipodystrophy syndrome: an update

      AIDS
    67. Toma, E; Devost, D; Lan, NC; Bhat, PV
      HIV-protease inhibitors alter retinoic acid synthesis

      AIDS
    68. Kosmiski, LA; Kuritzkes, DR; Lichtenstein, KA; Glueck, DH; Gourley, PJ; Stamm, ER; Scherzinger, AL; Eckel, RH
      Fat distribution and metabolic changes are strongly correlated and energy expenditure is increased in the HIV lipodystrophy syndrome

      AIDS
    69. Sattler, FR; Qian, D; Louie, S; Johnson, D; Briggs, W; DeQuattro, V; Dube, MP
      Elevated blood pressure in subjects with lipodystrophy

      AIDS
    70. Nolan, D; Mallal, S
      Getting to the HAART of insulin resistance

      AIDS
    71. Miserez, AR; Muller, PY; Barella, L; Schwietert, M; Erb, P; Vernazza, PL; Battegay, M
      A single-nucleotide polymorphism in the sterol-regulatory element-binding protein 1c gene is predictive of HIV-related hyperlipoproteinaemia

      AIDS
    72. Shikuma, CM; Hu, N; Milne, C; Yost, F; Waslien, C; Shimizu, S; Shiramizu, B
      Mitochondrial DNA decrease in subcutaneous adipose tissue of HIV-infected individuals with peripheral lipoatrophy

      AIDS
    73. Carr, A; Hudson, J; Chuah, J; Mallal, S; Law, M; Hoy, J; Doong, N; French, M; Smith, D; Cooper, DA
      HIV protease inhibitor substitution in patients with lipodystrophy: a randomized, controlled, open-label, multicentre study

      AIDS
    74. Mora, S; Sala, N; Bricalli, D; Zuin, G; Chiumello, G; Vigano, A
      Bone mineral loss through increased bone turnover in HIV-infected childrentreated with highly active antiretroviral therapy

      AIDS
    75. Zaera, MG; Miro, O; Pedrol, E; Soler, A; Picon, M; Cardellach, F; Casademont, J; Nunes, V
      Mitochondrial involvement in antiretroviral therapy-related lipodystrophy

      AIDS
    76. Lichtenstein, KA; Ward, DJ; Moorman, AC; Delaney, KM; Young, B; Palella, FJ; Rhodes, PH; Wood, KC; Holmberg, SD
      Clinical assessment of HIV-associated lipodystrophy in an ambulatory population

      AIDS
    77. Nolan, D; Upton, R; McKinnon, E; John, M; James, I; Adler, B; Roff, C; Vasikaran, S; Mallal, S
      Stable or increasing bone mineral density in HIV-infected patients treatedwith nelfinavir or indinavir

      AIDS
    78. Mercie, P; Viallard, JF; Thiebaut, R; Faure, I; Rispal, P; Leng, B; Pellegrin, JL
      Efavirenz-associated breast hypertrophy in HIV-infected patients

      AIDS
    79. Heydemann, A; Wheeler, MT; McNally, EM
      Cardiomyopathy in animal models of muscular dystrophy

      CURRENT OPINION IN CARDIOLOGY
    80. Cossarizza, A; Mussini, C; Vigano, A
      Mitochondria in the pathogenesis of lipodystrophy induced by anti-HIV antiretroviral drugs: actors or bystanders?

      BIOESSAYS
    81. Salas-Salvado, J; Garcia-Lorda, P
      The metabolic puzzle during the evolution of HIV infection

      CLINICAL NUTRITION
    82. Schwenk, A; Breuer, P; Kremer, G; Ward, L
      Clinical assessment of HIV-associated lipodystrophy syndrome: bioelectrical impedance analysis, anthropometry and clinical scores

      CLINICAL NUTRITION
    83. Hofman, P; Huerre, M
      Diagnostic pitfalls in infectious disease pathology

      ANNALES DE PATHOLOGIE
    84. Hruz, PW; Murata, H; Mueckler, M
      Adverse metabolic consequences of HIV protease inhibitor therapy: the search for a central mechanism

      AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
    85. Manfredi, R; Chiodo, F
      Disorders of lipid metabolism in patients with HIV disease treated with antiretroviral agents: Frequency, relationship with administered drugs, and role of hypolipidaemic therapy with bezafibrate

      JOURNAL OF INFECTION
    86. Duong, M; Buisson, M; Cottin, Y; Piroth, L; Lhuillier, I; Grappin, M; Chavanet, P; Wolff, JE; Portier, H
      Coronary heart disease associated with the use of human immunodeficiency virus (HIV)-1 protease inhibitors: Report of four cases and review

      CLINICAL CARDIOLOGY
    87. Brown, CA; Lanning, RW; McKinney, KQ; Salvino, AR; Cherniske, E; Crowe, CA; Darras, BT; Gominak, S; Greenberg, CR; Grosmann, C; Heydemann, P; Mendell, JR; Pober, BR; Sasaki, T; Shapiro, F; Simpson, DA; Suchowersky, O; Spence, JE
      Novel and recurrent mutations in lamin A/C in patients with Emery-Dreifussmuscular dystrophy

      AMERICAN JOURNAL OF MEDICAL GENETICS
    88. Fellay, J; Boubaker, K; Ledergerber, B; Bernasconi, E; Furrer, H; Battegay, M; Hirschel, B; Vernazza, P; Francioli, P; Greub, G; Flepp, M; Telenti, A
      Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study

      LANCET
    89. Martinez, E; Garcia-Viejo, MA; Blanch, J; Gatell, JM
      Lipodystrophy syndrome in patients with HIV infection - Quality of life issues

      DRUG SAFETY
    90. Weiel, JE; Lenhard, JM
      Chapter 13. In vitro and in vivo approaches to studying antiretroviral therapy (ART)-induced metabolic complications

      ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 36
    91. Roge, BT; Katzenstein, TL; Gerstoft, J
      Comparison of p-triglyceride levels among patients with human immunodeficiency virus on randomized treatment with ritonavir, indinavir or ritonavir/saquinavir

      SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
    92. Pond, CM
      Long-term changes in adipose tissue in human disease

      PROCEEDINGS OF THE NUTRITION SOCIETY
    93. Frayn, KN
      Adipose tissue and the insulin resistance syndrome

      PROCEEDINGS OF THE NUTRITION SOCIETY
    94. Ku, NO; Gish, R; Wright, TL; Omary, MB
      Keratin 8 mutations in patients with cryptogenic liver disease.

      NEW ENGLAND JOURNAL OF MEDICINE
    95. Paloneva, J; Autti, T; Raininko, R; Partanen, J; Salonen, O; Puranen, M; Hakola, P; Haltia, M
      CNS manifestations of Nasu-Hakola disease - A frontal dementia with bone cysts

      NEUROLOGY
    96. Tansey, JT; Sztalryd, C; Gruia-Gray, J; Roush, DL; Zee, JV; Gavrilova, O; Reitman, ML; Deng, CX; Li, C; Kimmel, AR; Londos, C
      Perilipin ablation results in a lean mouse with aberrant adipocyte lipolysis, enhanced leptin production, and resistance to diet-induced obesity

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    97. Phelps, RG; Shoji, T
      Update on panniculitis

      MOUNT SINAI JOURNAL OF MEDICINE
    98. Paglione, AM; Ferrari, N; Berg, G; Frechtel, G; Taverna, M; Fasulo, V; Lopez, GI; Gomez, RM; Bruno, O; Ruiz, M; Wikinski, RLW
      Acquired partial lipodystrophy. Insulin resistance, hepatic lipase activity and small and dense LDL particles.

      MEDICINA-BUENOS AIRES
    99. Gaou, I; Malliti, M; Guimont, MC; Letteron, P; Demeilliers, C; Peytavin, G; Degott, C; Pessayre, D; Fromenty, B
      Effect of stavudine on mitochondrial genome and fatty acid oxidation in lean and obese mice

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    100. Nadler, ST; Attie, AD
      Please pass the chips: Genomic insights into obesity and diabetes

      JOURNAL OF NUTRITION


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 02/06/20 alle ore 04:13:59